Stem Cell Agency Governing Board Meeting October 20-21, 2010

Day 1
Oct 20, 2010
Main Location: 

Luxe Hotel Sunset Boulevard
11461 Sunset Blvd.
Los Angeles, CA 90049

Additional Locations: 
Embassy Suites Chevy Chase Pavilion 4300 Military Road NW Washington, DC 20015
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
Call-in Information: 
http://205.144.147.162/cgi-bin/confCast Enter Conference ID# 171854. Then click Go.
Day 2
Oct 21, 2010
Main Location: 

Grand Horizon Room
Covel Commons
Sunset Village, UCLA
Los Angeles, CA 90095

Additional Locations: 
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
Call-in Information: 
http://205.144.147.162/cgi-bin/confCast Enter Conference ID# 171855. Then click Go.

Stem Cell Agency Governing Board Meeting

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT


EXPECTED ORDER OF EVENTS (Subject to change without notice)

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]


REPORTS

4. Chairman’s Report.

5. President’s Report.

6. Report regarding the financial implications of funding $243 million of Disease Team II awards.

7. Consideration of Strategic Financial Plan Projected Cash Flows.
* Robson Memo re. Projected Cash Flows
* Robson Projections

CLOSED SESSION

8. Discussion of Personnel [Evaluation of President] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

Public report of any action taken, if necessary, during closed session.


ACTION ITEMS

9. Consideration of recommendations from Grants Working Group regarding applications submitted in response to RFA 10-01: CIRM Early Translational II Research Awards.

A) Extraordinary Petition for Application TR2-01768
B) Extraordinary Petition for Application TR2-01785
C) Extraordinary Petition for Application TR2-01797
D) Extraordinary Petition for Application TR2-01763

10. Consideration of recommendation from Grants Working Group regarding application submitted in response to RFA 09-04: CIRM Research Leadership Awards.

CLOSED SESSION

11. Discussion of confidential intellectual property or work product, prepublication data, financial information, and confidential scientific research or data relating to applications for RFA 10-01: CIRM Early Translational II Research Awards and an application for RFA 09-04: CIRM Research Leadership Awards. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

Public report of any action taken, if necessary, during closed session.

ACTION ITEMS

12. Consideration of minutes from previous Board meeting.

13. Consideration of amendments to and adoption of Loan Administration Policy.
* MEMO re. LAP Amendments
* GUIDELINES for LAP Amendments

14. Consideration of proposal for Board option to request additional analysis issues arising from Grants Working Group, as recommended for approval by the Science Subcommittee.

15. Consideration of process for review of requests for change in scope to permit use of unused research award funds for human clinical trial research, when human research was not part of the original application, as recommended for consideration by the Science Subcommittee.


DISCUSSION ITEMS

16. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .
 

© 2013 California Institute for Regenerative Medicine